50
Participants
Start Date
March 31, 2001
Primary Completion Date
November 30, 2002
Study Completion Date
August 31, 2013
Gleevec
Starting dose of 400 mg orally daily.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
M.D. Anderson Cancer Center
OTHER